Search Within

Aaron David Goldberg

Formats
  1. Meeting Abstract (69)
  2. Journal Article (30)
  3. Research Letter (6)
  4. Correspondence (3)
  5. Editorial (3)
  6. Review (2)
  7. Book Section (1)
Groups
  1. Adult Leukemia (114)
  2. Center for Hematologic Malignancies (114)
  3. Department of Medicine (114)
  4. Hematologic Malignancies, Division of (114)
  5. Weinberg Fellows (114)
  6. Hematology-Oncology Fellows (52)

More Groups

People
  1. Martin Tallman (47)
  2. Eytan Stein (41)
  3. Christopher Famulare (37)
  4. Ross Levine (21)
  5. Andriy Derkach (20)
  6. Jan Bewersdorf (19)

More People

Years
  1. 2025 (2)
  2. 2024 (19)
  3. 2023 (20)
  4. 2022 (15)
  5. 2021 (15)
  6. 2020 (15)

More Years

Publications
  1. Blood (63)
  2. Leukemia and Lymphoma (8)
  3. American Journal of Hematology (6)
  4. Blood Advances (5)
  5. Journal of Clinical Oncology (5)
  6. Haematologica (4)

More Publications

Publishers
  1. American Society of Hematology (68)
  2. Taylor & Francis Group (8)
  3. American Society of Clinical Oncology (6)
  4. John Wiley & Sons, Inc. (6)
  5. Ferrata Storti Foundation (4)
  6. Nature Publishing Group (4)

More Publishers

Results (114)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML
    Journal Article

    Stahl, M.; Menghrajani, K.; Derkach, A.; Chan, A.; Xiao, W.; Glass, J.; King, A. C.; Daniyan, A. F.; Famulare, C.; Cuello, B. M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Outcomes of patients with hematologic malignancies and COVID-19 infection: A report from the ASH Research Collaborative Data Hub
    Meeting Abstract

    Wood, W. A.; Neuberg, D. S.; Thompson, J. C.; Tallman, M. S.; Sekeres, M. A.; Sehn, L. H.; Anderson, K.; Goldberg, A. D.; Pennell, N. A.; Niemeyer, C. M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Venetoclax therapy for relapsed and treatment refractory AML: Clinical outcomes and molecular predictors
    Meeting Abstract

    Stahl, M.; Menghrajani, K.; Derkach, A.; Chan, A.; Xiao, W.; Glass, J. L.; King, A. C.; Daniyan, A.; Famulare, C.; Cuello, B. M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Clinical outcomes of acute myeloid leukemia patients bridged to allogeneic stem cell transplant by venetoclax combination therapy
    Meeting Abstract

    Stahl, M.; Menghrajani, K.; Derkach, A.; DeWolf, S.; Ruiz, J. D.; Ponce, D. M.; Shaffer, B. C.; Tamari, R.; Young, J. W.; Barker, J.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Molecular predictors and effectiveness of measurable residual disease (MRD) eradication with chemotherapy and allogeneic stem cell transplantation for acute myeloid leukemia
    Meeting Abstract

    Stahl, M.; Derkach, A.; Famulare, C.; Cho, C.; Devlin, S.; Farnoud, N.; Menghrajani, K.; Patel, M. A.; Cai, S. F.; Geyer, M. B.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Characteristics and outcomes of newly diagnosed acute myeloid leukemia patients receiving venetoclax combinations vs other therapies: Results from the AML real world evidence (ARC) Initiative
    Meeting Abstract

    Pollyea, D. A.; Stahl, M.; Talati, C.; Asghari, H.; Lai, C.; Abedin, S.; Zeidner, J. F.; Muluneh, B.; Xavier, M.; Edwards, W.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Clinical benefit of crenolanib, with or without salvage chemotherapy, in multiply relapsed, FLT3 mutant AML patients after prior treatment with gilteritinib
    Meeting Abstract

    Goldberg, A. D.; Geyer, M. B.; Kell, J.; Di Bona, E.; Pardee, T. S.; Bhave, R.; Grunwald, M. R.; Marconi, G.; Wang, Y. J.; Pathan, A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Biomarker driven umbrella trial of crenolanib in combination with ivosidenib, enasidenib, venetoclax, vyxeos and/or salvage chemotherapy in FLT3 mutant AML
    Meeting Abstract

    Daver, N.; Goldberg, A. D.; DiNardo, C. D.; Kadia, T. M.; Wang, E. S.; Stone, R. M.; Zhang, H.; Messahel, B.
    Blood (2020)

    Fulltext@MSK | Save
  • Outcomes of patients with hematologic malignancies and COVID-19: A report from the ASH Research Collaborative Data Hub
    Journal Article

    Wood, W. A.; Neuberg, D. S.; Colton Thompson, J.; Tallman, M. S.; Sekeres, M. A.; Sehn, L. H.; Anderson, K. C.; Goldberg, A. D.; Pennell, N. A.; Niemeyer, C. M.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Single-cell mutation analysis of clonal evolution in myeloid malignancies
    Journal Article

    Miles, L. A.; Bowman, R. L.; Merlinsky, T. R.; Csete, I. S.; Ooi, A. T.; Durruthy-Durruthy, R.; Bowman, M.; Famulare, C.; Patel, M. A.; Mendez, P.; more...
    Nature (2020)

    Fulltext@MSK | Save